3,5-tetrahydroaldosterone sulfate (THAS)

09/01/2017 - "Multivariate analysis showed statistically significant associations with deep infections for BMI (BMI >40kg/m2 OR 5.62, 95% CI 2.25-14.0), male gender (OR 1.7, 95% CI 1.05-2.74) and age greater than 75 for THAs (age <55 years OR 0.35, 95% CI 0.14-0.87). "
01/01/2019 - "It was suggested that TM was protective against infection after revision and that TM may be useful when revising THAs for PJI. "
01/01/2001 - "In primary THAs, there was enhancement of quality of life, allowing restoration of full participation in normal activities; function was improved; radiologic evidence of loosening was low; and there were no infections. "
01/01/2023 - "In this study of 16,500 primary THAs, DAA was independently associated with an elevated risk of superficial infection reoperation compared to the PLA, but there was no association between surgical approach and PJI. "
12/01/2022 - "The purpose of this study was to look for potential associations between EOAP and differential rates of antimicrobial resistance or epidemiology of organisms causing periprosthetic joint infection (PJI) following primary and aseptic revision THAs/TKAs. "

11/27/2023 - "Hospitals performing a high volume of THAs for indications other than osteoarthritis should budget for an anticipated increase in costs, and orthopaedic surgeons should advocate for improved MS-DRG coding to appropriately reimburse hospitals for the financial and clinical risk of these surgeries. "
12/01/2003 - "To have comparable groups, only THAs performed because of primary osteoarthritis, using cemented implants with documented good results, and high-viscosity cement were included. "
10/01/2022 - "Studies reporting on primary THAs for osteoarthritis (OA) and that included PJI rates segregated by surgical approach were included. "
10/01/2020 - " - The study comprised 9,482 primary THAs due to osteoarthritis performed by 208 surgeons, where 91% of the included primary THAs were performed by orthopedic specialists and 9% by trainees. "
12/01/2018 - "After applying the inclusion criteria, the number of patients and THAs with a complete data set was determined to be 186,231, which accounted for 51% of all hips (366,309) with primary osteoarthritis operated on with THA of any head size and bearing type during the study observation time. "

04/01/2021 - "In contrast for TKAs, although male patients demonstrated the same pattern as the THAs, female TKAs displayed significantly less improvement in both OKS and its pain component following second-side surgery. "
02/01/2014 - "In this prospective, comparative, nonrandomized study of 120 patients (60 direct anterior THA, 60 posterior THAs), we assessed functional recovery using the VAS pain score, timed up and go (TUG) test, motor component of the Functional Independence Measure™ (M-FIM™), UCLA activity score, Harris hip score, and patient-maintained subjective milestone diary and general health outcome using SF-12 scores. "
07/01/2017 - "In HIV-positive patients, both THAs and TKAs are reliable in alleviating pain and improving clinical function at mid-term follow-up. "
01/01/2016 - "We identified 507 patients with 565 primary THAs with an MMPI prior to primary THA, of whom 441 patients with 488 primary THAs had responded to hip pain and function follow-up surveys at 2-years post-surgery. "
02/01/2014 - "There were no differences in articular wear, histology, MRI, and tissue damage between resurfacings and THAs revised for unexplained pain. "

12/01/2016 - "This study with the use of CoC bearings THAs in younger patients have shown promising results and higher rate of survivorship without evidence of osteolysis."
01/01/2009 - "Despite a strong correlation (r = 0.93, r(2) = 0.87) between these three variables and the volume of pelvic osteolysis measured on CT, estimates of pelvic osteolysis volume deviated from the actual volume measured on CT by more than 10 cm(3) among eight of the 78 THAs in this study. "
11/01/2022 - "Among 1,175 THAs, 220 osteolysis and 78 wear-related revisions were detected. "
01/01/2021 - "No THAs demonstrated evidence of osteolysis or component loosening at long-term follow-up. "
04/01/2020 - "Prosthetic wear particle-induced monocyte recruitment to the periprosthetic tissue and subsequent inflammatory response are thought to be the major contribution to AL. Fibroblast is a dominant cell type in interfacial membrane (IFM) which is the main pathological feature of periprosthetic osteolysis in failed THAs. "

02/01/2012 - "Although the incidence of malignant tumors in patients undergoing total hip arthroplasties (THAs) is known to be lower than the general population, there exist several reports on the development of malignant tumors at the site of THAs. "
02/01/2023 - "THAs are highly effective for achieving primary hemostasis in malignancy-related GI bleeding. "
02/01/2023 - "We conducted this systematic review and meta-analysis to evaluate the efficacy of THAs in malignancy-related GI bleeding. "
02/01/2023 - "We conducted a comprehensive search of multiple electronic databases to identify studies reporting on the use of THAs in malignancy-related GI bleeding. "
04/01/2022 - "Group A, 40 oncological cases (22 primary tumors; 18 metastases); Group B, 33 failed THAs. "